U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H16N2O2
Molecular Weight 208.2569
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOPILOCARPINE

SMILES

CC[C@@H]1[C@@H](CC2=CN=CN2C)COC1=O

InChI

InChIKey=QCHFTSOMWOSFHM-WCBMZHEXSA-N
InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10+/m0/s1

HIDE SMILES / InChI

Molecular Formula C11H16N2O2
Molecular Weight 208.2569
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Isopilocarpine is a diastereomer of pilocarpine. Isopilocarpine coexists with pilocarpine in nature and is also a degradation product of pilocarpine after oral administration to humans. It can be found in the leaves of some Pilocarpus species. Pilocarpine targets the muscarinic receptors and is approved for treatment of xerostomia. Isopilocarpine is often present in formulations of pilocarpine but has no appreciable effect on muscarinic receptors.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P41984
Gene ID: 281685.0
Gene Symbol: CHRM3
Target Organism: Bos taurus (Bovine)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Norepinephrine in treatment of ocular hypertension and glaucoma.
1975 Mar
[The effect of physiological and extreme irritants on zinc metabolism in pancreatic islets and hippocampus cells].
2001
Synchronized feeding as a "conditioned stimulus" for overt seizures in chronically (limbic) epileptic rats: a model for "psychogenic seizures" with complex partial epilepsy.
2001
A new medication for treatment of dry mouth in Sjögren's syndrome.
2001 Apr
Immediate diode laser peripheral iridoplasty as treatment of acute attack of primary angle closure glaucoma: a preliminary study.
2001 Apr
2-chloro-N(6)-cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats.
2001 Apr
Alkaline phosphatase activity in whitefly salivary glands and saliva.
2001 Apr
Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
2001 Apr
Stress response to surgical procedures in the submandibular region and its influence on salivary secretion in mice.
2001 Apr
Initiation of network bursts by Ca2+-dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy.
2001 Apr 1
Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy.
2001 Apr 17
Exploring the potential for subtype-selective muscarinic agonists in glaucoma.
2001 Apr 27
Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.
2001 Apr 27
Alteration of cardiovascular and neuronal function in M1 knockout mice.
2001 Apr 27
The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease.
2001 Aug
Beta-adrenergic blocker therapy and the trabecular meshwork.
2001 Feb
Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
2001 Feb
Brief successive temporal observational sampling as a possible indicator of daily overt seizure activity in epileptic rats.
2001 Feb
The acute effect of pilocarpine on pulsatile ocular blood flow in ocular hypertension.
2001 Feb
Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma.
2001 Feb
Normalization of spatial learning despite brain damage in rats receiving ketamine after seizure-induction: evidence for the neuromatrix.
2001 Feb
Do recurrent febrile convulsions decrease the threshold for pilocarpine-induced seizures? Effects of nitric oxide.
2001 Feb 28
Protection by selenium of lead-acetate-induced alterations on rat submandibular gland function.
2001 Jan
[Dry mouth].
2001 Jan 31
Reliable measurement of mouse intraocular pressure by a servo-null micropipette system.
2001 Jul
Prophylactic effects of pilocarpine hydrochloride on xerostomia models induced by X-ray irradiation in rats.
2001 Jul
Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine.
2001 Jul
Defective fluid secretion and NaCl absorption in the parotid glands of Na+/H+ exchanger-deficient mice.
2001 Jul 20
Evaluation of spontaneous contamination of ocular medications.
2001 Jul-Aug
Activity-induced expression of common reference genes in individual cns neurons.
2001 Jun
Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours.
2001 Jun
Potential mechanism for the additivity of pilocarpine and latanoprost.
2001 Jun
Behavioral and electroencephalographic analysis of seizures induced by intrahippocampal injection of granulitoxin, a neurotoxic peptide from the sea anemone Bunodosoma granulifera.
2001 Jun
Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies.
2001 Jun 1
Modulators with convergent cellular actions elicit distinct circuit outputs.
2001 Jun 1
Agonistic behavior in groups of limbic epileptic male rats: pattern of brain damage and moderating effects from normal rats.
2001 Jun 29
Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation.
2001 Jun 29
Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy.
2001 Jun 8
Normal spatial memory following postseizure treatment with ketamine: selective damage attenuates memory deficits in brain-damaged rodents.
2001 Mar
Cocaine abuse, generalized myasthenia, complete external ophthalmoplegia, and pseudotonic pupil.
2001 Mar
Brain-derived neurotrophic factor superinduction parallels anti-epileptic--neuroprotective treatment in the pilocarpine epilepsy model.
2001 Mar
Lithium does not synergize the peripheral action of cholinomimetics as seen in the central nervous system.
2001 Mar 23
In vivo evaluation of submicron emulsions with pilocarpine: the effect of pH and chemical form of the drug.
2001 Mar-Apr
Amino acid derivatives with anticonvulsant activity.
2001 May
Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease.
2001 May
Lack of effect of mossy fiber-released zinc on granule cell GABA(A) receptors in the pilocarpine model of epilepsy.
2001 May
Diurnal variation in pilocarpine-induced generalized tonic-clonic seizure activity.
2001 May
Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland.
2001 May 1
Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats.
2001 May 15
Loss of vesicular zinc and appearance of perikaryal zinc after seizures induced by pilocarpine.
2001 May 25
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: consumed orally as an impurity in pharmaceutical preparations of pilocarpine
Unknown
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:25:41 UTC 2023
Edited
by admin
on Sat Dec 16 08:25:41 UTC 2023
Record UNII
J9UV7D2OI9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ISOPILOCARPINE
Common Name English
3-ISOPILOCARPINE
Common Name English
PILOCARPINE IMPURITY, ISOPILOCARPINE- [USP IMPURITY]
Common Name English
PILOCARPINE HYDROCHLORIDE IMPURITY ISOPILOCARPINE [USP IMPURITY]
Common Name English
PILOCARPINE HYDROCHLORIDE IMPURITY A [EP IMPURITY]
Common Name English
(3R,4R)-3-ETHYL-4-((1-METHYL-1H-IMIDAZOL-5-YL)METHYL)DIHYDROFURAN-2(3H)-ONE
Systematic Name English
2(3H)-FURANONE, 3-ETHYLDIHYDRO-4-((1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-, (3R,4R)-
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
208-506-5
Created by admin on Sat Dec 16 08:25:41 UTC 2023 , Edited by admin on Sat Dec 16 08:25:41 UTC 2023
PRIMARY
PUBCHEM
91468
Created by admin on Sat Dec 16 08:25:41 UTC 2023 , Edited by admin on Sat Dec 16 08:25:41 UTC 2023
PRIMARY
CAS
531-35-1
Created by admin on Sat Dec 16 08:25:41 UTC 2023 , Edited by admin on Sat Dec 16 08:25:41 UTC 2023
PRIMARY
EPA CompTox
DTXSID701316166
Created by admin on Sat Dec 16 08:25:41 UTC 2023 , Edited by admin on Sat Dec 16 08:25:41 UTC 2023
PRIMARY
FDA UNII
J9UV7D2OI9
Created by admin on Sat Dec 16 08:25:41 UTC 2023 , Edited by admin on Sat Dec 16 08:25:41 UTC 2023
PRIMARY
CHEBI
39458
Created by admin on Sat Dec 16 08:25:41 UTC 2023 , Edited by admin on Sat Dec 16 08:25:41 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP